CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Oncaidia Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Oncaidia Limited
55 Jerningham Street
North Adelaide, SA  5006  Australia

This company is no longer actively traded on any major stock exchange.

Business Summary
Oncaidia Ltd., formerly Apomab Ltd, was established to focus on the research and development of products for the management of cancer. The Company holds an worldwide license to make, use and sell products derived from two technologies identified by researchers at the Hanson Institute, Adelaide, South Australia, these technologies, include the La technology and the telomerase technology respectively. The La technology is branded Apomab.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20076/30/2006Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Douglas P.LeMessurier
Managing Director, Director Ian K.Smith
Director Catherine M.Costello
Director Lusia H.Guthrie

General Information
Outstanding Shares: 96,358,770 (As of 9/17/2007)
Stock Exchange: ASX


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023